Tevogen Bio announced up to $10 million in grant funding to enhance cancer and viral infection therapies and AI initiatives. Tevogen Bio, a clinical-stage biotech company focused on immunotherapy, ...

Systemic Bio, a subsidiary of 3D Systems, has been named a Top 10 Finalist for the SLAS 2025 Innovation Award, recognizing its innovative h-VIOS platform designed to enhance drug discovery through ...

Tevogen Bio’s ExacTcell platform creates off-the-shelf T-cell therapies targeting viral infections, cancers, and neurological conditions with scalable production from a single donor. The company ...

A series of announcements in recent weeks shows just how much the spatial biology field has matured in the years since Nature Methods recognized spatial biology—which it called spatially resolved ...

From startups to giants in pharma and tools, the use of spatial biology is growing in importance in drug discovery. LatchBio, a four-year-old San Francisco builder of software and data infrastructure ...